Placeholder

Letter from the Editor

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 243. Category: .

Product Description

The Art of Communicating
The popular Verizon ad, “Can you hear me now?” sums up one of the major roadblocks in any business partnership or relationship: miscommunication.
No matter the relationship — client/provider, team/team, or person/person — the inability to clearly communicate represents one of the biggest barriers to effective business outcomes.
At the recent IIR Clinical Trials Congress (CTC) in February, during a roundtable discussion in which pharmaceutical and clinical service executives were discussing ways to get around clinical budget constraints, the conversation time and again returned to the need for good communications during the trial process. Likewise, this month’s Forum experts unanimously identified the need for good communications as one of the single most important components of building, maintaining, and sustaining ongoing partnerships. At the same time, these experts say lack of communication continues to be an ongoing stumbling block.
This poses the question: Why is there such a disconnect?

FEEDBACK